S.No | API Name | CAS NO | Therapeutic segment |
1 | Abiraterone Acetate | 154229-18-2 | Anti-androgens (anti-testosterone) |
2 | Alectinib | 1256580-46-7 | Antineoplastic Agents |
3 | Anastrozole | 120511-73-1 | Antineoplastic Agents |
4 | Apalutamide | 956104-40-8 | Antineoplastic Agents |
5 | Apixaban | 503612-47-3 | Anti-coagulant |
6 | Azacitidine | 320-67-2 | Antineoplastic Agents |
7 | Bicalutamide | 90357-06-5 | Antineoplastic Agents |
8 | Camostat mesylate | 59721-28-7 | Ant coronaviral agent |
9 | Canagliflozin Hemihydrate | 1809403-05-1 | Anti-diabetic |
10 | Dantrolene sodium | 14663-23-1 | Skeletal muscle relaxant |
11 | Dapagliflozin | 461432-26-8 | Anti-diabetic |
12 | Dasatinib | 302962-49-8 | Antineoplastic Agents |
13 | Docetaxel | 114977-28-5 | Antineoplastic Agents |
14 | Empagliflozin | 864070-44-0 | Anti-diabetic |
15 | Enoxaparin Sodium | 679809-58-6 | Anticoagulant |
16 | Enzalutamide | 915087-33-1 | Antineoplastic Agents |
17 | Esaxerenone | 1632006-28-0 | nsMRAs |
18 | Fingolimod hydrochloride | 162359-56-0 | Multiple sclerosis |
19 | Ibrutinib | 936563-96-1 | Antineoplastic Agents |
20 | Imatinib | 152459-95-5 | Antineoplastic Agents |
21 | Mirogabalin besylate | 1138245-21-2 | Pain management |
22 | Nafamostat mesylate | 82956-11-4 | Anticoagulant |
23 | Nitrofurantoin | 67-20-9 | Anti-Biotic |
24 | Pirfenidone | 53179-13-8 | Idiopathic pulmonary fibrosis |
25 | Posaconazole | 17122-49-2 | Anti-Fungal |
26 | Raltegravir Potassium | 871038-72-1 | HIV integrase inhibitor |
27 | Regorafenib | 755037-03-7 | Antineoplastic Agents |
28 | Rocuronium bromide | 119302-91-9 | Non-depolarizing muscle relaxant |
29 | R-Tetrahydro papaverine hydrochloride | 54417-53-7 | Neuromuscular blocking agent |
30 | Sitagliptin hydrochloride monohydrate | 862156-92-1 | Anti-diabetic |
31 | Sitagliptin phosphate monohydrate | 654671-77-9 | Anti-diabetic |
32 | Trientine hydrochloride | 38260-01-4 | Alimentary tract and metabolism product |
33 | Voriconazole | 137234-62-9 | Anti Fungal |
Note: Please feel free to contact for additional products requirements if any,
Our team will quickly support on your requirements – info@venrexpharma.com
DISCLAIMER:
PATENTS: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Products currently covered by valid Patents are offered for R&D use only.
Venrex Pharma assumes no responsibility/ liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Venrex Pharma makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
Venrex Pharma warns the sellers & buyers not to sell / buy any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.